In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Diploma for the Responsible Person for Information and Publicity (RIP)

Diploma for the Responsible Person for Information and Publicity (RIP)

by In2Pharma | Mar 22, 2023 | News

Belgium The Royal Decree of April 7, 1995 on information and publicity of medicinal products for human use, describing which diplomas are eligible for recognition as RIP is being amended. The adaptation is made to follow the evolution in terminology of the relevant...

Recent Posts

  • Update NDS-web platform
  • Maximum limits nutrients food supplements
  • Maximum hospitality limits increased
  • CGR publishes new maximum hourly rates for 2027
  • GAIA self-assessment on hospitality rules now also applies to medical device companies

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België